Skip to main content

Table 2 Overview of study assessments of APACH2 trial

From: Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2

 

Screening

(before inclusion)

Before surgery

Surgery

Follow-up

Month (M)

   

M

1

M

6

Informed consent

    

Medical and demographic history

    

Physical examination (weight, length)

    

Pregnancy (urinary or blood) test

(within 8 days)

    

Neck ultrasound

    

Blood testsa

  

FCH PET/CT and/or MIBI SPECT/CT

 

   

Adverse events

 

PHPT-related health care consumption

 

  1. aserum values of calcium, parathyroid hormone (PTH), albumin, phosphorus, vitamin D and creatinine, creatinine clearance calculated according to MDRD formula